Let's share

Our story


HTRIC drives innovation and carries out research within four development programmes, as presented in the overview below. These demand and ambition-driven programmes operate over the entire human life cycle: from healthy living, prevention and monitoring, diagnosis and treatment to revalidation.

The strengths present in Groningen – such as (molecular) imaging, artificial intelligence, big (health) data, robotics and material technology – are reflected in all three programmes in order to meet societal challenges. Our programmes also support the nationally defined priority areas in MedTech NL.

1. Operating Theatre of the Future

Surgical techniques with calculated accuracy

The implementation of robot-assisted, high complexity operations in surgery is taking place steadily. Current systems will evolve towards high-tech computer platforms, where diagnostics and multi-modular treatments are integrated, and AI plays an essential part. Developments within HTRIC include the integration of perioperative ‘decision control’ in the next generation of robot platforms, the improvement of robot arm placement in robotic surgery and the development of nano-robotics.

Schelto Kruijff

Raffaella Carloni

Esther Consten

Marleen Kamperman

Max Witjes

2. Replacement and Improvement in the Human Body

From biomaterials to 3D technology

Modern medicine cannot exist without the use of biomaterials and nanotechnology. Groningen’s expertise offers a major contribution to the development of new, innovative materials, such as nature-inspired water-resistant adhesives with potential applications in surgical procedures and nanogels for coatings. Work is being done on the reconstruction of organs using 3D technology, while organoid models are being developed both in vivo and in vitro for the isolation and characterisation of stem cells.

3. Innovative Technology with Local Precision

Observation, monitoring and targeted treatment

Monitoring plays a significant role in the clinical setting as well as at home. By using personalised devices (sensors and diagnostic tools), we strive to develop innovative and personalised health technology that is not only used to promote personal healthcare management, but also to enable diagnostics and treatment tailored to the patient. One of our strengths here in Groningen lies in the combination of imaging and nanoscience/nanotechnology. We are known internationally for our pioneering research on photoactive polymers developed for photopharmacology purposes.

Wiktor Szymanski

Ajay Kottapalli